<DOC>
	<DOC>NCT01853397</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety, efficacy, and tolerability of treatment with the Liposonix System (Model 2)using a single pass technique.</brief_summary>
	<brief_title>Evaluation of the Treatment of Adipose Tissue With Liposonix System (Model 2) Using a New Treatment Method</brief_title>
	<detailed_description />
	<criteria>Male or female, 18 to 65 years of age Body Mass Index of ≤30 kg/m2 Thickness of subcutaneous adipose tissue in the anticipated treatment area of ≥ 2.3 cm Subjects must agree to not alter their normal and regular diet or exercise routines during the course of the study Subject must understand the nature of the study and sign an IRB approved Informed Consent Subject is pregnant Subject is diagnosed with coagulation disorders or are receiving anticoagulant therapy or medications or dietary supplements which impede coagulation or platelet aggregation Subject has diabetes or cardiovascular disease Subject has had prior aesthetic procedures to the region to be treated Subject has had previous open or laparoscopic surgery in the anticipated treatment area Subject is on prescription or over the counter weight reduction medication or programs, or had weight reduction procedures Subjects undergoing chronic steroid or immunosuppressive therapy Subject has cardiac pacemakers or any implantable electrical device Subject has a History of cancer Subject has sensory loss or dysesthesia in the area to be treated Subjects who are unable, or lack the capacity, to self consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>